Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature
Open accessThe DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index; 33 of the 40 sources its claims cite were checked for support.
Abstract
The senescence-associated secretory phenotype (SASP) is a generic term for the secretion of cytokines, such as pro-inflammatory factors and proteases. It is a crucial feature of senescent cells. SASP factors induce tissue remodeling and immune cell recruitment. Previous studies have focused on the beneficial role of SASP during embryonic development, wound healing, tissue healing in general, immunoregulation properties, and cancer. However, some recent studies have identified several negative effects of SASP on fracture healing. Senolytics is a drug that selectively eliminates senescent cells. Senolytics can inhibit the function of senescent cells and SASP, which has been found to have positive effects on a variety of aging-related diseases. At the same time, recent data suggest that removing senescent cells may promote fracture healing. Here, we reviewed the latest research progress about SASP and illustrated the inflammatory response and the influence of SASP on fracture healing. This review aims to understand the role of SASP in fracture healing, aiming to provide an important clinical prevention and treatment strategy for fracture. Clinical trials of some senolytics agents are underway and are expected to clarify the effectiveness of their targeted therapy in the clinic in the future. Meanwhile, the adverse effects of this treatment method still need further study.
Overview
CoChat Summary
## TL;DR
This is a narrative review arguing that senescence-associated secretory phenotype (SASP) influences fracture healing, with the literature suggesting that SASP can be both harmful and, in some contexts, potentially reparative. The paper emphasizes that senolytics and other SASP-targeting strategies may help fracture healing, but the mechanisms, dosing, and safety remain uncertain.
## Key findings
- Public data analyses cited in the review showed that markers of aging and SASP increase during fracture healing, and that fracture healing time is reduced in mice treated with drugs that remove senescent cells.
- In one fracture-healing tissue study using qRT-PCR, most SASP-related components increased rapidly; CCL7 increased 70-fold at day 14, and Pai1/Serpine1 increased more than 60-fold at day 8 but decreased substantially by day 14.
- The review reports that IL-6 and TNF-α generally inhibit bone formation and promote osteoclast activity, while TGF-β has context-dependent effects; partial neutralization of TGF-β with antibodies accelerated fracture healing in aged mice.
- Senolytics such as dasatinib + quercetin were reported to downregulate aging markers in fracture-healing tissue and improve healing in mice, but navitoclax (ABT-263) was also associated with trabecular bone loss and impaired bone formation in aged mice.
## Methods
- Narrative review of the current literature on SASP, cellular senescence, and fracture healing.
- Synthesizes prior studies, including public data analyses, qRT-PCR findings in fracture-healing tissues, and animal studies of senolytics and TGF-β neutralization.
- Main analysis is qualitative integration of published mechanistic and preclinical evidence; no meta-analysis or systematic review method is stated in the text.
## Limitations
- The paper states that the mechanisms are not yet precise and that further studies are needed to clarify how SASP affects fracture healing and whether SASP-targeted treatment will promote fracture healing.
- The review explicitly notes that there are relatively few experimental studies on SASP in fracture healing and that the exact composition of SASP remains elusive.
- Evident from the text: most of the support comes from preclinical and literature-synthesis evidence, with clinical applicability still uncertain; the paper also says the specific dosing method for senolytics “still needs to be simpler” and that adverse effects need further study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
27 Valid · 2 Not valid · 5 Not checked · 5 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“interleukins showed a significant increase at the beginning of fracture healing, such as IL-6 and IL-17 [3].”
§ Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature > SASP in fracture healing
What the sources say
- Partly supportedcites [3] Saul D, Monroe DG, Rowsey JL, Kosinsky RL, Vos SJ, Doolittle ML, et al. Modulation of fracture healing by the transient accumulation of senescent cells. elife. 2021. https://doi.org/10.7554/eLife.69958. sourceExperimental — accuracy not yet measured
The Results section on SASP expression in the fracture callus says Il6 and Il17a gene expression rose during the first days after fracture in mice. It does not specifically state that both increases were statistically significant; the Figure 4 caption also describes Il17a as gradually declining after its early rise. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“One study found more IL-6 from BMSCs from older adults than younger adults”
§ Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature > SASP in fracture healing > IL-6
What the sources say
- Partly supportedcites [83] Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schafer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 2013;11:146. sourceExperimental — accuracy not yet measured
The Results section (Figure 5C) reports more IL-6 in the supernatant of BM-MSCs from older donors than younger donors, but only when the cells were co-cultured with activated allogeneic T cells. The citing sentence omits that experimental condition and reads as a general claim about IL-6 secretion. (LLM, conf=0.86)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“fracture healing time is reduced after using drugs in mice to remove senescent cells [3]”
§ Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature > Introduction
What the sources say
- Supportedcites [3] Saul D, Monroe DG, Rowsey JL, Kosinsky RL, Vos SJ, Doolittle ML, et al. Modulation of fracture healing by the transient accumulation of senescent cells. elife. 2021. https://doi.org/10.7554/eLife.69958. source
The Results section reports significantly improved fracture-healing kinetics in mice treated with the senolytic drugs dasatinib plus quercetin and concludes that treatment accelerated the time course of healing. It also reports reduced senescence markers after treatment. The study was conducted in young adult mice. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“An analysis of public data displayed that markers of aging and SASP do increase during fracture healing”
§ Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature > Introduction
What the sources say
- Supportedcites [3] Saul D, Monroe DG, Rowsey JL, Kosinsky RL, Vos SJ, Doolittle ML, et al. Modulation of fracture healing by the transient accumulation of senescent cells. elife. 2021. https://doi.org/10.7554/eLife.69958. source
The Results section reports that analysis of publicly available mouse fracture-healing mRNA-seq data found increased expression of the senescence markers Cdkn1aCip1 and Cdkn2aInk4a. The Discussion reports a substantial increase in SASP factors during fracture healing. No page numbers are available in our copy. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“One study reported that accelerated fracture healing was observed in aged mice after partial neutralization of TGF-β with TGF antibodies [4].”
§ Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature > Introduction
What the sources say
- Partly supportedcites [4] Liu J, Zhang J, Lin X, Boyce BF, Zhang H, Xing L. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. J Clin Invest. 2022. https://doi.org/10.1172/JCI148073. sourceExperimental — accuracy not yet measured
The Results section ('Anti–TGF-β–neutralizing Abs enhance fracture healing in aged mice'; page not provided) reports improved callus volume, new bone area, and bone strength in aged mice given the TGF-β-neutralizing antibody 1D11. The paper does not establish that the neutralization was partial, so that qualifier is unsupported. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
18 more claims · 10 with their cited sources checked
Create a free account to see all 39 claims and every source verdict.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Ye F, Li J, Xu P, Xie Z, Zheng G, Liu W, et al. Osteogenic differentiation of mesenchymal stem cells promotes c-Jun-dependent secretion of interleukin 8 and mediates the migration and differentiation of CD4(+) T cells. Stem Cell Res Ther. 2022;13(1):58.”
Cited work 10.1186/s13287-022-02735-0 · retracted 2025-10-09 · notice 10.1186/s13287-025-04714-7 · this paper published 2024-01-09
Citations
Cites
1 retracted
Ye, F., Li, J., Xu, P., Xie, Z., Zheng, G., Liu, W., Ye, G., Yu, W., Lin, J., Su, Z., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02735-0 · Cited by 35
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · cited 1×
“Osteoblasts themselves secrete GM-CSF, which is involved in promoting osteoclast differentiation and maturation [77].”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Hundreds of SASP have been reported, among which the most common of factors include interleukin IL-1a, IL-6, and IL-1, and others such as IFN-γ, VEGF, ICAM-1, and GM-CSF [10, 13, 14], and some are released in the form of the exosome [14, 15].”
BackgroundThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“IL-1a is an upstream regulator of other SASP and regulates the secretion of other SASP [8, 16, 28].”
BackgroundCellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 1×
“It has been confirmed that high-mobility group box 1protein (HMGA1) is involved in the regulation of the secretion of pro-inflammatory SASPs (IL-6, IL-8, etc.) through the regulation of NAMPT and ultimately the NAD/NADH ratio [43], and that pro-inflammatory SASP has a pro-tumorigenic effect [44].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192 · cited 1×
“It is an essential part of the locomotor system [48].”
Background
Cited by
Alqahtani, S., Alqahtani, T., Venkatesan, K., Sivadasan, D., Ahmed, R., Sirag, N., Elfadil, H., Mohamed, H. A., A, H., Ahmed, R. E., et al. (2025) · Cells · doi:10.3390/cells14080608 · Cited by 108
“In conditions such as osteoarthritis and pulmonary fibrosis, SASP-activated fibroblasts drive abnormal collagen accumulation and reduce ECM turnover, even in the absence of inflammatory cytokines [93].”
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
“215 Such therapies could reduce the risk of fractures, improve muscle strength, and enhance mobility in the elderly.”
Klepacki, H., Kowalczuk, K., Łepkowska, N., & Hermanowicz, J. M. (2025) · Cells · doi:10.3390/cells14130942 · Cited by 57
“Those molecules help modulate the inflammatory response and stimulate the repair and remodeling of bone tissue following an injury [90].”
Sahu, P., & Satapathy, T. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01867-y · Cited by 35
“Together, these strategies aim to restore immune balance, promote efficient senescent cell clearance, and mitigate the detrimental effects of long-standing inflammation, ultimately supporting healthier tissue maintenance and improved physiological resilience (Zhao et al. 2024).”
Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants
Tufail, M., Huang, Y., Hu, J.-J., Liang, J., He, C., Wan, W., Jiang, C., Wu, H., & Li, N. (2024) · Aging and Disease · doi:10.14336/ad.2024.0421 · Cited by 49
“Senolytic drugs inducing senescent cell death or senomorphics suppressing SASP represent pioneering approaches to manipulate the tumor microenvironment and optimize treatment outcomes [111].”
Metadata
- Authors
- Zhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- University Hospital Zurich (CH)
- Chinese PLA General Hospital (CN)
- Beijing Friendship Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Corresponding author
- Liu, Hongjian
- Venue
- European Journal of Medical Research
- Published
- 2024-01-09
- Volume
- 29
- Issue
- 1
- Pages
- 38-38
- ISSN
- 0949-2321 (ISSN-L)
- 2047-783X
- PMC
- PMC10775505
- OpenAlex
- W4390744430
- Cited by
- 35
- References
- 143
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 3
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- European journal of medical research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Natural Science Foundation of China (82172484)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- senescence-associated secretory phenotype, fracture healing, cellular senescence, senolytics, senolytic therapy, inflammation, inflammatory cytokines, proteolytic enzymes, tissue remodeling, immune cell recruitment, age-related diseases
- MeSH terms
- Senescence-Associated Secretory Phenotype, Senotherapeutics, Female, Humans, Pregnancy, Cytokines, Fracture Healing, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature. https://app.cochat.ai/papers/10.1186/s40001-023-01604-7
- The paper
- Zhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H. (2024). Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature. European Journal of Medical Research. https://doi.org/10.1186/s40001-023-01604-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.